

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | uterus development (GO:0060065) | 4.39477683 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 3.95764167 |
| 3 | COPI coating of Golgi vesicle (GO:0048205) | 3.95764167 |
| 4 | vagina development (GO:0060068) | 3.94406831 |
| 5 | protein localization to endosome (GO:0036010) | 3.92184598 |
| 6 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.76838062 |
| 7 | negative regulation of fatty acid transport (GO:2000192) | 3.36876262 |
| 8 | iron ion import (GO:0097286) | 3.29745193 |
| 9 | apoptotic cell clearance (GO:0043277) | 3.15661665 |
| 10 | endocrine hormone secretion (GO:0060986) | 3.15086829 |
| 11 | surfactant homeostasis (GO:0043129) | 3.13794921 |
| 12 | regulation of early endosome to late endosome transport (GO:2000641) | 3.07264010 |
| 13 | female genitalia development (GO:0030540) | 3.05633530 |
| 14 | low-density lipoprotein particle clearance (GO:0034383) | 3.05495033 |
| 15 | extracellular negative regulation of signal transduction (GO:1900116) | 3.05185445 |
| 16 | extracellular regulation of signal transduction (GO:1900115) | 3.05185445 |
| 17 | sodium ion export (GO:0071436) | 3.03553395 |
| 18 | regulation of steroid hormone biosynthetic process (GO:0090030) | 3.03235961 |
| 19 | wound healing, spreading of epidermal cells (GO:0035313) | 3.01053437 |
| 20 | keratan sulfate catabolic process (GO:0042340) | 2.97450248 |
| 21 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.92549021 |
| 22 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.92131611 |
| 23 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.91535512 |
| 24 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.88105408 |
| 25 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.87477933 |
| 26 | vesicle coating (GO:0006901) | 2.83297831 |
| 27 | skin morphogenesis (GO:0043589) | 2.82972874 |
| 28 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.82210483 |
| 29 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.81727588 |
| 30 | focal adhesion assembly (GO:0048041) | 2.78350691 |
| 31 | cell-substrate adherens junction assembly (GO:0007045) | 2.78350691 |
| 32 | desmosome organization (GO:0002934) | 2.75815349 |
| 33 | * female pregnancy (GO:0007565) | 2.75598201 |
| 34 | adherens junction assembly (GO:0034333) | 2.73976649 |
| 35 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.73206271 |
| 36 | estrogen biosynthetic process (GO:0006703) | 2.73117130 |
| 37 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.70938879 |
| 38 | positive regulation of receptor recycling (GO:0001921) | 2.69155139 |
| 39 | membrane raft organization (GO:0031579) | 2.65824758 |
| 40 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.64436975 |
| 41 | striated muscle atrophy (GO:0014891) | 2.64319257 |
| 42 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.64249718 |
| 43 | clathrin coat assembly (GO:0048268) | 2.63055022 |
| 44 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.62217484 |
| 45 | barbed-end actin filament capping (GO:0051016) | 2.61541633 |
| 46 | basement membrane organization (GO:0071711) | 2.60221353 |
| 47 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.58657510 |
| 48 | sphingosine metabolic process (GO:0006670) | 2.58084726 |
| 49 | cell-substrate junction assembly (GO:0007044) | 2.57104578 |
| 50 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.55151798 |
| 51 | triglyceride catabolic process (GO:0019433) | 2.53178969 |
| 52 | chondrocyte development (GO:0002063) | 2.52716855 |
| 53 | collagen fibril organization (GO:0030199) | 2.52245822 |
| 54 | intestinal epithelial cell development (GO:0060576) | 2.51100495 |
| 55 | type B pancreatic cell proliferation (GO:0044342) | 2.50078914 |
| 56 | parturition (GO:0007567) | 2.49702189 |
| 57 | chemical homeostasis within a tissue (GO:0048875) | 2.49260563 |
| 58 | protein heterotrimerization (GO:0070208) | 2.47369648 |
| 59 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.46817343 |
| 60 | bone trabecula formation (GO:0060346) | 2.44812032 |
| 61 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.44566769 |
| 62 | regulation of hormone biosynthetic process (GO:0046885) | 2.43147419 |
| 63 | peptidyl-proline hydroxylation (GO:0019511) | 2.42653604 |
| 64 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 2.42102517 |
| 65 | epithelial cell-cell adhesion (GO:0090136) | 2.40502963 |
| 66 | neutral lipid catabolic process (GO:0046461) | 2.40227152 |
| 67 | acylglycerol catabolic process (GO:0046464) | 2.40227152 |
| 68 | cell adhesion mediated by integrin (GO:0033627) | 2.40023632 |
| 69 | skeletal muscle adaptation (GO:0043501) | 2.39811217 |
| 70 | glomerular basement membrane development (GO:0032836) | 2.37664147 |
| 71 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.37292456 |
| 72 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.36680224 |
| 73 | ear development (GO:0043583) | 2.35457231 |
| 74 | negative regulation of cell-matrix adhesion (GO:0001953) | 2.34551011 |
| 75 | protein retention in ER lumen (GO:0006621) | 2.32300050 |
| 76 | cellular potassium ion homeostasis (GO:0030007) | 2.31943133 |
| 77 | sphingoid metabolic process (GO:0046519) | 2.31886076 |
| 78 | mammary gland epithelial cell proliferation (GO:0033598) | 2.31703222 |
| 79 | wound healing, spreading of cells (GO:0044319) | 2.30227920 |
| 80 | regulation of gonadotropin secretion (GO:0032276) | 2.29450376 |
| 81 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.28681902 |
| 82 | import into cell (GO:0098657) | 2.28674839 |
| 83 | mating behavior (GO:0007617) | 2.26387568 |
| 84 | protein hydroxylation (GO:0018126) | 2.24968646 |
| 85 | protein targeting to plasma membrane (GO:0072661) | 2.24300655 |
| 86 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.23987180 |
| 87 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.23794342 |
| 88 | 4-hydroxyproline metabolic process (GO:0019471) | 2.23769081 |
| 89 | positive regulation of macrophage cytokine production (GO:0060907) | 2.23056099 |
| 90 | ovulation cycle (GO:0042698) | 2.23033086 |
| 91 | diol metabolic process (GO:0034311) | 2.22988830 |
| 92 | positive regulation of fibroblast migration (GO:0010763) | 2.21784624 |
| 93 | COPII vesicle coating (GO:0048208) | 2.20638732 |
| 94 | cellular copper ion homeostasis (GO:0006878) | 2.20075094 |
| 95 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.19895378 |
| 96 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.19541743 |
| 97 | prostate gland growth (GO:0060736) | 2.19223301 |
| 98 | positive regulation of endothelial cell migration (GO:0010595) | 2.19114591 |
| 99 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.18488499 |
| 100 | glomerular visceral epithelial cell development (GO:0072015) | 2.18067079 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.74129434 |
| 2 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 3.46596301 |
| 3 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.04122364 |
| 4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.03563022 |
| 5 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.03001019 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.94682046 |
| 7 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.62283765 |
| 8 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.61048241 |
| 9 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.58067195 |
| 10 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.56552760 |
| 11 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.49094777 |
| 12 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.40425403 |
| 13 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.33389120 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.11816336 |
| 15 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.09250509 |
| 16 | AHR_22903824_ChIP-Seq_MCF-7_Human | 2.07035553 |
| 17 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.05904788 |
| 18 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 2.03266272 |
| 19 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.94590638 |
| 20 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.89425011 |
| 21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.85988455 |
| 22 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.80806979 |
| 23 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.80794186 |
| 24 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.74357656 |
| 25 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.72369009 |
| 26 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.69402852 |
| 27 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.69358375 |
| 28 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.68870089 |
| 29 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.68422943 |
| 30 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.68070321 |
| 31 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.67829249 |
| 32 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.65490226 |
| 33 | GATA1_22025678_ChIP-Seq_K562_Human | 1.64239979 |
| 34 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.62193250 |
| 35 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.62193250 |
| 36 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.56530014 |
| 37 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.52180414 |
| 38 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.49487269 |
| 39 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.49334880 |
| 40 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.48348801 |
| 41 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.47914935 |
| 42 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.46557693 |
| 43 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.46557693 |
| 44 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.46431092 |
| 45 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.45999072 |
| 46 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.43542909 |
| 47 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.35249599 |
| 48 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.33182712 |
| 49 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.33017414 |
| 50 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.31729137 |
| 51 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.27964483 |
| 52 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26432496 |
| 53 | CJUN_26792858_Chip-Seq_BT549_Human | 1.25604747 |
| 54 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24587717 |
| 55 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.23389831 |
| 56 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.23281371 |
| 57 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.23246561 |
| 58 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.22743893 |
| 59 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.21998078 |
| 60 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.20873833 |
| 61 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.17069599 |
| 62 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.16283517 |
| 63 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.16156773 |
| 64 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.15830875 |
| 65 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.13956379 |
| 66 | KDM2B_26808549_Chip-Seq_K562_Human | 1.13598996 |
| 67 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.13318911 |
| 68 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.13318911 |
| 69 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.13101778 |
| 70 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.12985977 |
| 71 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.12777311 |
| 72 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.12651518 |
| 73 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.10892873 |
| 74 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.10826624 |
| 75 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.08935600 |
| 76 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.08880287 |
| 77 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.08279811 |
| 78 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.07886617 |
| 79 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.07466450 |
| 80 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.07156892 |
| 81 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.06359870 |
| 82 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.05649279 |
| 83 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.05145142 |
| 84 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.05145142 |
| 85 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.05119287 |
| 86 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.02992097 |
| 87 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.02201187 |
| 88 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.02062599 |
| 89 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.00055750 |
| 90 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.98537810 |
| 91 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.97469396 |
| 92 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.97178952 |
| 93 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.97053241 |
| 94 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.96963767 |
| 95 | TP53_16413492_ChIP-PET_HCT116_Human | 0.95111712 |
| 96 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.93205171 |
| 97 | RXR_22108803_ChIP-Seq_LS180_Human | 0.92776460 |
| 98 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.92303105 |
| 99 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.91791790 |
| 100 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.91126976 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 5.32567451 |
| 2 | MP0009780_abnormal_chondrocyte_physiolo | 4.28674015 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 4.27682620 |
| 4 | MP0005503_abnormal_tendon_morphology | 3.64271744 |
| 5 | MP0005275_abnormal_skin_tensile | 3.37072299 |
| 6 | MP0010234_abnormal_vibrissa_follicle | 3.17294507 |
| 7 | MP0004782_abnormal_surfactant_physiolog | 2.78720406 |
| 8 | MP0001958_emphysema | 2.55874100 |
| 9 | MP0010386_abnormal_urinary_bladder | 2.43990476 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.42343209 |
| 11 | MP0003941_abnormal_skin_development | 2.26356901 |
| 12 | MP0005257_abnormal_intraocular_pressure | 2.23074498 |
| 13 | MP0004264_abnormal_extraembryonic_tissu | 2.19639811 |
| 14 | MP0002877_abnormal_melanocyte_morpholog | 2.13318681 |
| 15 | MP0003566_abnormal_cell_adhesion | 2.13229879 |
| 16 | MP0002876_abnormal_thyroid_physiology | 2.08519334 |
| 17 | MP0004272_abnormal_basement_membrane | 2.07485138 |
| 18 | MP0002796_impaired_skin_barrier | 1.93585002 |
| 19 | MP0003950_abnormal_plasma_membrane | 1.89537818 |
| 20 | MP0000751_myopathy | 1.80967211 |
| 21 | MP0005646_abnormal_pituitary_gland | 1.80137601 |
| 22 | MP0003183_abnormal_peptide_metabolism | 1.77814807 |
| 23 | MP0000003_abnormal_adipose_tissue | 1.77310683 |
| 24 | MP0003279_aneurysm | 1.77066435 |
| 25 | MP0002971_abnormal_brown_adipose | 1.71511495 |
| 26 | MP0002896_abnormal_bone_mineralization | 1.68397573 |
| 27 | MP0003091_abnormal_cell_migration | 1.61424036 |
| 28 | MP0005666_abnormal_adipose_tissue | 1.58072096 |
| 29 | MP0005375_adipose_tissue_phenotype | 1.58034728 |
| 30 | MP0010352_gastrointestinal_tract_polyps | 1.57391655 |
| 31 | MP0005023_abnormal_wound_healing | 1.50362404 |
| 32 | MP0005670_abnormal_white_adipose | 1.44534704 |
| 33 | MP0003879_abnormal_hair_cell | 1.39394111 |
| 34 | MP0005623_abnormal_meninges_morphology | 1.39245096 |
| 35 | MP0009115_abnormal_fat_cell | 1.38481002 |
| 36 | MP0002108_abnormal_muscle_morphology | 1.36816056 |
| 37 | MP0000767_abnormal_smooth_muscle | 1.33399855 |
| 38 | MP0004185_abnormal_adipocyte_glucose | 1.31553687 |
| 39 | MP0000681_abnormal_thyroid_gland | 1.31404296 |
| 40 | MP0001542_abnormal_bone_strength | 1.31111361 |
| 41 | MP0003959_abnormal_lean_body | 1.30961970 |
| 42 | MP0002060_abnormal_skin_morphology | 1.27356843 |
| 43 | MP0006138_congestive_heart_failure | 1.27157633 |
| 44 | MP0003868_abnormal_feces_composition | 1.25107622 |
| 45 | MP0000627_abnormal_mammary_gland | 1.25006111 |
| 46 | MP0005076_abnormal_cell_differentiation | 1.24874862 |
| 47 | MP0004233_abnormal_muscle_weight | 1.22677215 |
| 48 | MP0004130_abnormal_muscle_cell | 1.22670881 |
| 49 | MP0005058_abnormal_lysosome_morphology | 1.20980874 |
| 50 | MP0004484_altered_response_of | 1.19236064 |
| 51 | MP0002998_abnormal_bone_remodeling | 1.12859941 |
| 52 | MP0006054_spinal_hemorrhage | 1.11330062 |
| 53 | MP0003828_pulmonary_edema | 1.09671216 |
| 54 | MP0000013_abnormal_adipose_tissue | 1.09014031 |
| 55 | MP0010678_abnormal_skin_adnexa | 1.06295756 |
| 56 | MP0000747_muscle_weakness | 1.05920405 |
| 57 | MP0003453_abnormal_keratinocyte_physiol | 1.04901034 |
| 58 | MP0005647_abnormal_sex_gland | 1.00586050 |
| 59 | MP0002295_abnormal_pulmonary_circulatio | 0.99735607 |
| 60 | MP0001348_abnormal_lacrimal_gland | 0.99542728 |
| 61 | MP0005409_darkened_coat_color | 0.99372885 |
| 62 | MP0000759_abnormal_skeletal_muscle | 0.97835521 |
| 63 | MP0004087_abnormal_muscle_fiber | 0.97484738 |
| 64 | MP0009384_cardiac_valve_regurgitation | 0.96506078 |
| 65 | MP0003329_amyloid_beta_deposits | 0.95448310 |
| 66 | MP0001727_abnormal_embryo_implantation | 0.94875007 |
| 67 | MP0004859_abnormal_synaptic_plasticity | 0.94638308 |
| 68 | MP0004858_abnormal_nervous_system | 0.93765102 |
| 69 | MP0003045_fibrosis | 0.90812921 |
| 70 | MP0005165_increased_susceptibility_to | 0.90808919 |
| 71 | MP0005164_abnormal_response_to | 0.87365091 |
| 72 | MP0008004_abnormal_stomach_pH | 0.87167180 |
| 73 | MP0002098_abnormal_vibrissa_morphology | 0.85783540 |
| 74 | MP0002168_other_aberrant_phenotype | 0.85687376 |
| 75 | MP0005451_abnormal_body_composition | 0.84600837 |
| 76 | MP0008874_decreased_physiological_sensi | 0.84054333 |
| 77 | MP0010368_abnormal_lymphatic_system | 0.78802034 |
| 78 | MP0001849_ear_inflammation | 0.78179836 |
| 79 | MP0005388_respiratory_system_phenotype | 0.77678612 |
| 80 | MP0002133_abnormal_respiratory_system | 0.77678612 |
| 81 | MP0005508_abnormal_skeleton_morphology | 0.77395786 |
| 82 | MP0005501_abnormal_skin_physiology | 0.75791392 |
| 83 | MP0003936_abnormal_reproductive_system | 0.75447217 |
| 84 | MP0000343_altered_response_to | 0.75062945 |
| 85 | MP0010771_integument_phenotype | 0.74218504 |
| 86 | MP0001177_atelectasis | 0.71561006 |
| 87 | MP0000427_abnormal_hair_cycle | 0.69146811 |
| 88 | MP0001881_abnormal_mammary_gland | 0.67610076 |
| 89 | MP0003690_abnormal_glial_cell | 0.67179215 |
| 90 | MP0002970_abnormal_white_adipose | 0.63653804 |
| 91 | MP0002269_muscular_atrophy | 0.63423938 |
| 92 | MP0001968_abnormal_touch/_nociception | 0.63305364 |
| 93 | MP0002736_abnormal_nociception_after | 0.62671574 |
| 94 | MP0001440_abnormal_grooming_behavior | 0.61009010 |
| 95 | MP0005408_hypopigmentation | 0.58819911 |
| 96 | MP0000733_abnormal_muscle_development | 0.58705990 |
| 97 | MP0000604_amyloidosis | 0.58615815 |
| 98 | MP0004036_abnormal_muscle_relaxation | 0.58275014 |
| 99 | MP0000163_abnormal_cartilage_morphology | 0.56251262 |
| 100 | MP0001879_abnormal_lymphatic_vessel | 0.56191217 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 5.42540128 |
| 2 | Premature rupture of membranes (HP:0001788) | 4.57895090 |
| 3 | Vascular tortuosity (HP:0004948) | 4.30652484 |
| 4 | Arterial tortuosity (HP:0005116) | 4.10214112 |
| 5 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.54327306 |
| 6 | Osteolytic defects of the hand bones (HP:0009699) | 3.54327306 |
| 7 | Aortic aneurysm (HP:0004942) | 3.39695575 |
| 8 | Wormian bones (HP:0002645) | 3.24372375 |
| 9 | Cervical subluxation (HP:0003308) | 3.21288122 |
| 10 | Vertebral compression fractures (HP:0002953) | 3.04671049 |
| 11 | Aortic dissection (HP:0002647) | 3.04568332 |
| 12 | Asymmetric septal hypertrophy (HP:0001670) | 2.88028211 |
| 13 | Ankle contracture (HP:0006466) | 2.87260321 |
| 14 | Asymmetry of the thorax (HP:0001555) | 2.75709124 |
| 15 | Cerebral aneurysm (HP:0004944) | 2.63735678 |
| 16 | Macroorchidism (HP:0000053) | 2.62146008 |
| 17 | Increased variability in muscle fiber diameter (HP:0003557) | 2.54443437 |
| 18 | Spondylolisthesis (HP:0003302) | 2.52898125 |
| 19 | Bundle branch block (HP:0011710) | 2.50461031 |
| 20 | Increased connective tissue (HP:0009025) | 2.48229797 |
| 21 | Absent frontal sinuses (HP:0002688) | 2.47433151 |
| 22 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.47174025 |
| 23 | Mucopolysacchariduria (HP:0008155) | 2.47174025 |
| 24 | Blue sclerae (HP:0000592) | 2.45476280 |
| 25 | Spinal rigidity (HP:0003306) | 2.45059276 |
| 26 | Abnormality of glycolipid metabolism (HP:0010969) | 2.43546384 |
| 27 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.43546384 |
| 28 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.43546384 |
| 29 | Overgrowth (HP:0001548) | 2.41517981 |
| 30 | Dilatation of the ascending aorta (HP:0005111) | 2.32401290 |
| 31 | Bladder diverticulum (HP:0000015) | 2.32197877 |
| 32 | Cardiovascular calcification (HP:0011915) | 2.30564948 |
| 33 | Broad metatarsal (HP:0001783) | 2.27355888 |
| 34 | Mitral stenosis (HP:0001718) | 2.27124999 |
| 35 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.26134146 |
| 36 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.26134146 |
| 37 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.26134146 |
| 38 | Follicular hyperkeratosis (HP:0007502) | 2.25837309 |
| 39 | Hypoplasia of the iris (HP:0007676) | 2.23772056 |
| 40 | Soft skin (HP:0000977) | 2.23361217 |
| 41 | Flared iliac wings (HP:0002869) | 2.23151935 |
| 42 | Abnormality of the frontal sinuses (HP:0002687) | 2.22150351 |
| 43 | Enlarged penis (HP:0000040) | 2.21767939 |
| 44 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.20110673 |
| 45 | Dysostosis multiplex (HP:0000943) | 2.19836441 |
| 46 | Termporal pattern (HP:0011008) | 2.19402527 |
| 47 | Insidious onset (HP:0003587) | 2.19402527 |
| 48 | Aneurysm (HP:0002617) | 2.19396533 |
| 49 | Hyporeflexia of lower limbs (HP:0002600) | 2.18454976 |
| 50 | Type 1 muscle fiber predominance (HP:0003803) | 2.18328855 |
| 51 | J-shaped sella turcica (HP:0002680) | 2.17364448 |
| 52 | Thin bony cortex (HP:0002753) | 2.07816160 |
| 53 | Striae distensae (HP:0001065) | 2.04387205 |
| 54 | Cerebral inclusion bodies (HP:0100314) | 2.03812535 |
| 55 | Ovoid vertebral bodies (HP:0003300) | 1.99618987 |
| 56 | Fragile skin (HP:0001030) | 1.98145039 |
| 57 | Abnormality of the acetabulum (HP:0003170) | 1.98117597 |
| 58 | Atrioventricular block (HP:0001678) | 1.97345802 |
| 59 | Mitral valve prolapse (HP:0001634) | 1.96487059 |
| 60 | Spinal cord compression (HP:0002176) | 1.96478247 |
| 61 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.92566113 |
| 62 | Distal lower limb amyotrophy (HP:0008944) | 1.91464033 |
| 63 | Atrophic scars (HP:0001075) | 1.90551954 |
| 64 | Back pain (HP:0003418) | 1.89592017 |
| 65 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.89230123 |
| 66 | Shallow orbits (HP:0000586) | 1.88660278 |
| 67 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.88413279 |
| 68 | Action tremor (HP:0002345) | 1.88404648 |
| 69 | Hypercortisolism (HP:0001578) | 1.86998524 |
| 70 | Persistence of primary teeth (HP:0006335) | 1.86870295 |
| 71 | Abnormality of proline metabolism (HP:0010907) | 1.86349987 |
| 72 | Hydroxyprolinuria (HP:0003080) | 1.86349987 |
| 73 | Ulnar deviation of the wrist (HP:0003049) | 1.83743252 |
| 74 | Mitral regurgitation (HP:0001653) | 1.83093651 |
| 75 | Hyperextensible skin (HP:0000974) | 1.83055701 |
| 76 | Elbow flexion contracture (HP:0002987) | 1.82485387 |
| 77 | Neurofibrillary tangles (HP:0002185) | 1.81277460 |
| 78 | Vascular calcification (HP:0004934) | 1.79463259 |
| 79 | Flat acetabular roof (HP:0003180) | 1.77379939 |
| 80 | Right ventricular cardiomyopathy (HP:0011663) | 1.76461645 |
| 81 | Abnormal atrioventricular conduction (HP:0005150) | 1.76182486 |
| 82 | Joint laxity (HP:0001388) | 1.75545759 |
| 83 | Craniofacial hyperostosis (HP:0004493) | 1.73994225 |
| 84 | Joint stiffness (HP:0001387) | 1.71786272 |
| 85 | Aortic valve stenosis (HP:0001650) | 1.71523346 |
| 86 | Dysmetric saccades (HP:0000641) | 1.71315307 |
| 87 | Short nail (HP:0001799) | 1.70418517 |
| 88 | Distal lower limb muscle weakness (HP:0009053) | 1.70132228 |
| 89 | Microglossia (HP:0000171) | 1.69260760 |
| 90 | Disproportionate tall stature (HP:0001519) | 1.69153799 |
| 91 | Sparse lateral eyebrow (HP:0005338) | 1.69045868 |
| 92 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.68999607 |
| 93 | Spinal cord lesions (HP:0100561) | 1.67890193 |
| 94 | Syringomyelia (HP:0003396) | 1.67890193 |
| 95 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.67625085 |
| 96 | Lower limb amyotrophy (HP:0007210) | 1.66533771 |
| 97 | Neonatal hypoglycemia (HP:0001998) | 1.63836232 |
| 98 | Aortic regurgitation (HP:0001659) | 1.63570285 |
| 99 | Glucose intolerance (HP:0000833) | 1.61484851 |
| 100 | Achilles tendon contracture (HP:0001771) | 1.60438728 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.80108107 |
| 2 | ERN1 | 3.50995280 |
| 3 | LATS2 | 3.32591354 |
| 4 | PDGFRA | 2.90130116 |
| 5 | NEK9 | 2.66412304 |
| 6 | RIPK1 | 2.42510492 |
| 7 | LATS1 | 2.36769008 |
| 8 | MAP3K9 | 2.28123980 |
| 9 | MAP3K12 | 2.11178010 |
| 10 | MST1R | 2.09644807 |
| 11 | PKN2 | 2.09296923 |
| 12 | SCYL2 | 2.03420992 |
| 13 | MYLK | 1.99207997 |
| 14 | EEF2K | 1.94857561 |
| 15 | PAK2 | 1.87207225 |
| 16 | PRPF4B | 1.73926522 |
| 17 | TESK1 | 1.70201570 |
| 18 | EPHA2 | 1.66981931 |
| 19 | STK39 | 1.66239416 |
| 20 | ICK | 1.63178475 |
| 21 | STK38 | 1.58447587 |
| 22 | TRPM7 | 1.52888675 |
| 23 | DDR2 | 1.51768979 |
| 24 | MAP3K13 | 1.46720293 |
| 25 | ARAF | 1.40534217 |
| 26 | TGFBR2 | 1.37048508 |
| 27 | FGFR4 | 1.34580000 |
| 28 | SIK1 | 1.31097745 |
| 29 | PAK4 | 1.30448377 |
| 30 | MOS | 1.20283665 |
| 31 | PDPK1 | 1.17685577 |
| 32 | PTK2 | 1.16965145 |
| 33 | IRAK3 | 1.16918729 |
| 34 | STK38L | 1.16735190 |
| 35 | PIK3CA | 1.12085813 |
| 36 | PDGFRB | 1.10612923 |
| 37 | MAPKAPK3 | 1.10348746 |
| 38 | KSR2 | 1.09367998 |
| 39 | MET | 1.08089897 |
| 40 | GRK5 | 1.05291616 |
| 41 | PDK2 | 1.01610161 |
| 42 | NEK6 | 0.89388729 |
| 43 | OXSR1 | 0.89015015 |
| 44 | AKT2 | 0.87305326 |
| 45 | MAP2K1 | 0.86805536 |
| 46 | RPS6KA2 | 0.84925506 |
| 47 | LIMK1 | 0.84518216 |
| 48 | AKT3 | 0.81384901 |
| 49 | LRRK2 | 0.80694011 |
| 50 | NTRK1 | 0.80290685 |
| 51 | CDK12 | 0.78729672 |
| 52 | MAPK12 | 0.77592345 |
| 53 | MAPK11 | 0.76828158 |
| 54 | CDC42BPA | 0.75779126 |
| 55 | PDK1 | 0.74611243 |
| 56 | CDK6 | 0.74456040 |
| 57 | PAK6 | 0.74410239 |
| 58 | MAP3K2 | 0.70917169 |
| 59 | JAK1 | 0.70601080 |
| 60 | MTOR | 0.68914677 |
| 61 | PRKD2 | 0.68741688 |
| 62 | PRKCH | 0.68333126 |
| 63 | RET | 0.67362857 |
| 64 | TTN | 0.66715544 |
| 65 | DAPK2 | 0.64406083 |
| 66 | ROCK2 | 0.61038368 |
| 67 | ILK | 0.60902690 |
| 68 | SMG1 | 0.60352712 |
| 69 | BRAF | 0.59717806 |
| 70 | DMPK | 0.56846070 |
| 71 | PRKD1 | 0.56404750 |
| 72 | SIK3 | 0.55496197 |
| 73 | FER | 0.54709033 |
| 74 | DAPK3 | 0.53674142 |
| 75 | PTK6 | 0.51891185 |
| 76 | MELK | 0.50991660 |
| 77 | DAPK1 | 0.50025578 |
| 78 | PRKCI | 0.49912099 |
| 79 | MAP3K6 | 0.49190340 |
| 80 | BMPR2 | 0.47932808 |
| 81 | MARK2 | 0.47711917 |
| 82 | MST4 | 0.45714452 |
| 83 | TYRO3 | 0.45704687 |
| 84 | RIPK4 | 0.45321669 |
| 85 | FGFR3 | 0.44049281 |
| 86 | MAP3K7 | 0.43154784 |
| 87 | PRKG2 | 0.41672820 |
| 88 | PRKAA2 | 0.41178530 |
| 89 | MAP3K3 | 0.40210005 |
| 90 | MAPK4 | 0.39792644 |
| 91 | MAP2K3 | 0.38921865 |
| 92 | MAPK7 | 0.38336528 |
| 93 | RPS6KB1 | 0.36965597 |
| 94 | ADRBK1 | 0.35534340 |
| 95 | RPS6KB2 | 0.34013191 |
| 96 | CDK18 | 0.32599356 |
| 97 | SGK3 | 0.32490731 |
| 98 | EIF2AK3 | 0.32437467 |
| 99 | ABL1 | 0.31517337 |
| 100 | CDK15 | 0.31421533 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.22066069 |
| 2 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.10685235 |
| 3 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.01240998 |
| 4 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.77710591 |
| 5 | Focal adhesion_Homo sapiens_hsa04510 | 1.69999117 |
| 6 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.68124166 |
| 7 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.58357437 |
| 8 | Other glycan degradation_Homo sapiens_hsa00511 | 1.54000436 |
| 9 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.53521169 |
| 10 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.49013601 |
| 11 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.48559044 |
| 12 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.45347952 |
| 13 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.41350806 |
| 14 | Long-term potentiation_Homo sapiens_hsa04720 | 1.40071931 |
| 15 | Thyroid cancer_Homo sapiens_hsa05216 | 1.32687917 |
| 16 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.31493517 |
| 17 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.25384144 |
| 18 | Lysosome_Homo sapiens_hsa04142 | 1.22410701 |
| 19 | Glioma_Homo sapiens_hsa05214 | 1.22342796 |
| 20 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.21309416 |
| 21 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.20066796 |
| 22 | Endometrial cancer_Homo sapiens_hsa05213 | 1.18628072 |
| 23 | Adherens junction_Homo sapiens_hsa04520 | 1.17836713 |
| 24 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.13495642 |
| 25 | Amoebiasis_Homo sapiens_hsa05146 | 1.13102978 |
| 26 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.11815086 |
| 27 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.11180624 |
| 28 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.10002064 |
| 29 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.08854084 |
| 30 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.07781582 |
| 31 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.06935191 |
| 32 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.05941631 |
| 33 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.05036037 |
| 34 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.04826932 |
| 35 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.03484197 |
| 36 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.02581581 |
| 37 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.00936745 |
| 38 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.00754610 |
| 39 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.00309576 |
| 40 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.98094580 |
| 41 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.98057337 |
| 42 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.96956238 |
| 43 | Salivary secretion_Homo sapiens_hsa04970 | 0.96429583 |
| 44 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.94893684 |
| 45 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.94643226 |
| 46 | Galactose metabolism_Homo sapiens_hsa00052 | 0.94576864 |
| 47 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.92254018 |
| 48 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.90448045 |
| 49 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.90385952 |
| 50 | Prostate cancer_Homo sapiens_hsa05215 | 0.88548981 |
| 51 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.88082964 |
| 52 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.87982691 |
| 53 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.87754387 |
| 54 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.87266482 |
| 55 | Endocytosis_Homo sapiens_hsa04144 | 0.87265673 |
| 56 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.87190874 |
| 57 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.85587203 |
| 58 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.85321757 |
| 59 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.84822198 |
| 60 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.84494150 |
| 61 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.83119644 |
| 62 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.82665825 |
| 63 | Gap junction_Homo sapiens_hsa04540 | 0.81981990 |
| 64 | Melanogenesis_Homo sapiens_hsa04916 | 0.80013869 |
| 65 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.79637456 |
| 66 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.78716137 |
| 67 | Prion diseases_Homo sapiens_hsa05020 | 0.76890889 |
| 68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.75958786 |
| 69 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.75830825 |
| 70 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.75801304 |
| 71 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.75796721 |
| 72 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.75703807 |
| 73 | Bladder cancer_Homo sapiens_hsa05219 | 0.75641634 |
| 74 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.75536734 |
| 75 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.74699800 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.74343552 |
| 77 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.73897456 |
| 78 | Melanoma_Homo sapiens_hsa05218 | 0.73844274 |
| 79 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.73804558 |
| 80 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70950781 |
| 81 | Mineral absorption_Homo sapiens_hsa04978 | 0.70874424 |
| 82 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.69981868 |
| 83 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.69534745 |
| 84 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.69433880 |
| 85 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.68998728 |
| 86 | Histidine metabolism_Homo sapiens_hsa00340 | 0.68940609 |
| 87 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.68786312 |
| 88 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.68353948 |
| 89 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.63385302 |
| 90 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.62152203 |
| 91 | Renin secretion_Homo sapiens_hsa04924 | 0.62072130 |
| 92 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.60153232 |
| 93 | Tight junction_Homo sapiens_hsa04530 | 0.59905064 |
| 94 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.57949067 |
| 95 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.57563207 |
| 96 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.57192761 |
| 97 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.57100697 |
| 98 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.57029090 |
| 99 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.56794437 |
| 100 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.56153132 |

